Close Menu

USPTO

NEW YORK (GenomeWeb News) – Genetic Technologies today said that the US Patent and Trademark Office has affirmed the validity of certain claims of a primary non-coding DNA patent held by the Australian firm.

Title: RNA Sequence-Specific Mediators of RNA Interference
Patent Number: 8,394,628
Filed: Oct. 4, 2010
Lead Inventor: Thomas Tuschl, Max Planck Institute

Title: microRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors
Patent Number: 8,389,210
Filed: Feb. 4, 2010
Lead Inventor: Carlo Croce, Ohio State University

Title: Methods for Quantification of microRNAs and Small Interfering RNAs
Patent Number: 8,383,344
Filed: June 1, 2009
Lead Inventor: Nana Jacobsen, Exiqon

Title: microRNA-Based Methods and Compositions for the Diagnosis, Prognosis, and Treatment of Lung Cancer Using miR-17-3p
Patent Number: 8,377,637
Filed: March 30, 2011

Title: Method of Diagnosing Acute Lymphomic Leukemia Using miR-146a
Patent Number: 8,372,586
Filed: Oct. 17, 2011
Inventor: Carlo Croce, Ohio State University

Title: Screening of microRNA Cluster Inhibitor Pools
Patent Number: 8,367,318
Filed: July 21, 2008
Lead Inventor: Anja Smith, Dharmacon (Thermo Fisher Scientific)

Title: Method for Diagnosing Acute Lymphomic Leukemia Using miR-221
Patent Number: 8,361,722
Filed: Oct. 17, 2011
Inventor: Carlo Croce, Ohio State University

Title: Cyclodextrin-Based Materials, Compositions, and Uses Related Thereto
Patent Number: 8,357,377
Filed: Oct. 8, 2003

Title: microRNA Fingerprints During Human Megakaryocytopoiesis
Patent Number: 8,354,224
Filed: June 27, 2011
Lead Inventor: Carlo Croce, Ohio State University

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.